Skip to main content

Table 3 International recommendations of respiratory component of PPE for protection of HCWs performing AGPs in suspected or conformed COVID-19 patients

From: Use of powered air-purifying respirator (PAPR) by healthcare workers for preventing highly infectious viral diseases—a systematic review of evidence

International governing body/institution Face filtering piece (FFP) (in addition to other PPE) Powered air-purifying respirator (PAPR) (in addition to other PPE)
European Centre for Disease (ECDC) FFP2/FFP3 Use of PAPR not considered
Centers for Disease Control and Prevention (CDC) At least N95 Use of PAPR not considered
Public Health of England FFP3 Use of PAPR not considered
The Communicable Disease Network Australia (CDNA) FFP/N95 Consider the use of PAPR if remaining in the room with patient with suspected/confirmed COVID-19 positive patient longer than 1 h
  1. Abbreviations: FFP face filtering piece, PPE personal protective equipment, HCW healthcare workers, AGP aerosol-generated procedures